Upper Gastrointestinal Bleeding Clinical Trial
Official title:
Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS): A Pragmatic Randomized Trial to Evaluate Clinician Outreach to Reduce Upper Gastrointestinal Bleeding Risk in Patients Taking Warfarin and Antiplatelet Therapy
This study is a pragmatic cluster randomized controlled trial to evaluate the effectiveness of a clinician-facing implementation strategy on the use of medication optimization (defined as either discontinuation of all antiplatelet therapy or initiation of and adherence to a proton pump inhibitor (PPI)) to reduce upper GI bleeding risk in patients prescribed anticoagulant-antiplatelet therapy (AAT) relative to usual care.
This is a pragmatic, single-center cluster randomized controlled trial to evaluate a clinician-facing implementation strategy to increase the use of evidence-based practices (EBPs) to reduce bleeding in patients who are using AAT and who are managed by the Michigan Medicine anticoagulation monitoring service. The active intervention is clinician notification with nurse facilitation (CNNF), which consists of an anticoagulation clinic nurse sending an electronic health record message that identifies the patient as high risk for upper GI bleeding and recommends either discontinuing the antiplatelet agent or initiating a PPI; the nurse also pends medication orders for PPIs and provides patient education upon request. Clinicians will be cluster randomized, such that up to 4 patients cared for by each clinician will receive the same clinician-level notification. This study will use a "wait-listed design," in which patients will be randomized to either have their clinicians receive CNNF or be included in a wait-list control group. At the completion of the study, the patients who were randomized to the wait-list control group will receive the intervention. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02537353 -
Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip
|
Phase 4 | |
Recruiting |
NCT03624517 -
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
|
Phase 4 | |
Suspended |
NCT03337256 -
Direct Discharge of Patients With Upper Gastrointestinal Bleeding From the Emergency Department After Endoscopy
|
N/A | |
Completed |
NCT04472364 -
HemoPill Acute ® in Suspected Nonvariceal Upper Gastrointestinal Bleeding
|
N/A | |
Recruiting |
NCT00414713 -
Transfusion Requirements in Gastrointestinal (GI) Bleeding
|
Phase 4 | |
Completed |
NCT03680950 -
Efficacy Test of Real-Time Upper Gastrointestinal Monitoring System
|
N/A | |
Completed |
NCT05085405 -
Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial
|
N/A | |
Recruiting |
NCT06077916 -
Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy
|
N/A | |
Recruiting |
NCT04902248 -
OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding
|
N/A | |
Completed |
NCT02446678 -
Use of PillCam ESO2 in Triaging Patients Present With Upper GIB
|
N/A | |
Completed |
NCT05631639 -
Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study
|
N/A | |
Completed |
NCT02978391 -
UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD
|
N/A | |
Completed |
NCT00045799 -
Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill
|
Phase 3 | |
Recruiting |
NCT03090945 -
Pediatric Acute Gastrointestinal Bleeding Registry
|
||
Recruiting |
NCT06192355 -
Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding.
|
N/A | |
Recruiting |
NCT06297954 -
Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding
|
Phase 3 | |
Recruiting |
NCT03785080 -
Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients
|
N/A | |
Completed |
NCT03667703 -
Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease
|
Phase 4 | |
Terminated |
NCT02017379 -
Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.
|
N/A | |
Completed |
NCT01155401 -
Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding
|
N/A |